1 From the Research Service, First (Columbia University) Division, Goldwater Memorial Hospital and the Department of Medicine, College of Physicians and Sturgeons, Columbia University, New York, N. Y.
The oral administration of large amounts of sitosterol to patients with coronary atherosclerosis has resulted in statistically significant decrease in serum cholesterol in one half of the trial periods. However, because of the fluctuation of the serum cholesterol that occurs in patients with coronary atherosclerosis, further study will be necessary to demonstrate that the decrease in serum cholesterol coincident with sitosterol administration is not due to the lability of the serum lipids in this group of individuals.
© 1957 American Heart Association, Inc.
Effect of Sitosterol on the Concentration of Serum Lipids in Patients with Coronary Atherosclerosis
This article has been cited by other articles:
![]() |
A. H. Lichtenstein and R. J. Deckelbaum Stanol/Sterol Ester-Containing Foods and Blood Cholesterol Levels : A Statement for Healthcare Professionals From the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association Circulation, February 27, 2001; 103(8): 1177 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gylling, P. Puska, E. Vartiainen, and T. A. Miettinen Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population J. Lipid Res., April 1, 1999; 40(4): 593 - 600. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1957 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |